Provectus Biopharmaceuticals Presents Data from PV-10® Treatment of Metastatic Uveal Melanoma Patients in Two Oral Presentations at 2022 International Society of Ocular Oncology (ISOO) Congress
June 30, 2022 13:42 ET
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, June 30, 2022 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that updated data from the Company’s initial expansion cohort of patients with uveal melanoma metastatic to...
Molecular Imaging Market to be worth US$ 6,445.8 Mn by 2027 with CAGR 7.5% - Future Market Insights
December 20, 2017 03:38 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
Valley Cottage, New York, Dec. 20, 2017 (GLOBE NEWSWIRE) -- The global molecular imaging market is prognosticated to witness a tremendous growth in coming times. The worldwide molecular imaging...